IMTX
Immatics N.V

927
Mkt Cap
$1.26B
Volume
434,061.00
52W High
$11.25
52W Low
$3.30
PE Ratio
-9.45
IMTX Fundamentals
Price
$10.10
Prev Close
$10.33
Open
$10.45
50D MA
$9.06
Beta
1.15
Avg. Volume
1.02M
EPS (Annual)
$0.1557
P/B
2.56
Rev/Employee
$398,499.48
Loading...
Loading...
News
all
press releases
Immatics (NASDAQ:IMTX) Shares Up 6.7% Following Analyst Upgrade
Immatics (NASDAQ:IMTX) Trading 6.7% Higher Following Analyst Upgrade...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Immatics (NASDAQ:IMTX) Price Target Raised to $19.00 at Guggenheim
Guggenheim raised their target price on shares of Immatics from $16.00 to $19.00 and gave the stock a "buy" rating in a report on Tuesday...
MarketBeat·1d ago
News Placeholder
Immatics N.V. (NASDAQ:IMTX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Immatics N.V. (NASDAQ:IMTX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six analysts that are covering the company, MarketBeat reports. One...
MarketBeat·2d ago
News Placeholder
Company News for Nov 18, 2025
Companies in The News Are: ARMK,JJSF,IMTX,TWST
Zacks·2d ago
News Placeholder
Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates
Immatics (IMTX) delivered earnings and revenue surprises of +2.00% and -50.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Fox Run Management L.L.C. Acquires New Position in Immatics N.V. $IMTX
Fox Run Management L.L.C. bought a new position in Immatics N.V. (NASDAQ:IMTX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
CG Oncology, Inc. (CGON) Reports Q3 Loss, Tops Revenue Estimates
CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of 0.00% and +412.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Immatics (NASDAQ:IMTX) Stock Price Up 8% - Here's Why
Immatics (NASDAQ:IMTX) Trading Up 8% - Here's What Happened...
MarketBeat·7d ago
News Placeholder
Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates
Xilio Therapeutics (XLO) delivered earnings and revenue surprises of 0.00% and -28.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Beats Revenue Estimates
Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of +14.29% and +11.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago

Latest IMTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.